AustralineCAS# 118396-02-4 |
- Alexine
Catalog No.:BCN2054
CAS No.:116174-63-1
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 118396-02-4 | SDF | Download SDF |
PubChem ID | 442628 | Appearance | Powder |
Formula | C8H15NO4 | M.Wt | 189.21 |
Type of Compound | Alkaloids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | (1R,2R,3R,7S,8R)-3-(hydroxymethyl)-2,3,5,6,7,8-hexahydro-1H-pyrrolizine-1,2,7-triol | ||
SMILES | C1CN2C(C(C(C2C1O)O)O)CO | ||
Standard InChIKey | AIQMLBKBQCVDEY-OZRXBMAMSA-N | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 1. Australine is a potent and specific inhibitor of amyloglucosidase. 2. Australine inhibits the glycoprotein processing enzyme glucosidase I, and has slight activity toward glucosidase II. |
Australine Dilution Calculator
Australine Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 5.2851 mL | 26.4257 mL | 52.8513 mL | 105.7027 mL | 132.1283 mL |
5 mM | 1.057 mL | 5.2851 mL | 10.5703 mL | 21.1405 mL | 26.4257 mL |
10 mM | 0.5285 mL | 2.6426 mL | 5.2851 mL | 10.5703 mL | 13.2128 mL |
50 mM | 0.1057 mL | 0.5285 mL | 1.057 mL | 2.1141 mL | 2.6426 mL |
100 mM | 0.0529 mL | 0.2643 mL | 0.5285 mL | 1.057 mL | 1.3213 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Licoricesaponin A3
Catalog No.:BCN7905
CAS No.:118325-22-7
- Tazarotene
Catalog No.:BCC2540
CAS No.:118292-40-3
- 6-O-Acetylscandoside
Catalog No.:BCN8320
CAS No.:118292-15-2
- AF-DX 384
Catalog No.:BCC7024
CAS No.:118290-26-9
- Lafutidine
Catalog No.:BCC4544
CAS No.:118288-08-7
- Isodorsmanin A
Catalog No.:BCN6460
CAS No.:118266-99-2
- 1,4-Dicaffeoylquinic acid
Catalog No.:BCN5912
CAS No.:1182-34-9
- Soyasaponin Ab
Catalog No.:BCN2896
CAS No.:118194-13-1
- EMD638683
Catalog No.:BCC1551
CAS No.:1181770-72-8
- 2-Picenecarboxylic acid
Catalog No.:BCN3063
CAS No.:118172-80-8
- 6-Oxo-23-norpristimerol
Catalog No.:BCN8054
CAS No.:118172-79-5
- 6''-O-Acetylastragalin
Catalog No.:BCN6058
CAS No.:118169-27-0
- Trimethylamine oxide
Catalog No.:BCN1819
CAS No.:1184-78-7
- AG-18
Catalog No.:BCC1051
CAS No.:118409-57-7
- UNC 926 hydrochloride
Catalog No.:BCC2445
CAS No.:1184136-10-4
- nTZDpa
Catalog No.:BCC7268
CAS No.:118414-59-8
- MK 886
Catalog No.:BCC7017
CAS No.:118414-82-7
- Licoricesaponin G2
Catalog No.:BCN7897
CAS No.:118441-84-2
- Arcyriaflavin A
Catalog No.:BCC7370
CAS No.:118458-54-1
- Cyclo(L-Phe-trans-4-hydroxy-L-Pro)
Catalog No.:BCN3989
CAS No.:118477-06-8
- Fmoc-D-Tyr(tBu)-OH
Catalog No.:BCC3569
CAS No.:118488-18-9
- 5,7-Dichlorokynurenic acid sodium salt
Catalog No.:BCC7758
CAS No.:1184986-70-6
- TRIS hydrochloride
Catalog No.:BCC7589
CAS No.:1185-53-1
- Myelin Basic Protein (87-99)
Catalog No.:BCC1028
CAS No.:118506-26-6
Synthesis of multibranched australine derivatives from reducing castanospermine analogues through the Amadori rearrangement of gem-diamine intermediates: selective inhibitors of beta-glucosidase.[Pubmed:25390345]
J Org Chem. 2014 Dec 5;79(23):11722-8.
A practical one-pot synthesis of bi- and triantennated Australine analogues from a pivotal sp(2)-iminosugar-type reducing castanospermine precursor is reported. The transformation involves a gem-diamine intermediate that undergoes the indolizidine --> pyrrolizidine Amadori-type rearrangement and proceeds under strict control of the generalized anomeric effect to afford a single diastereomer. The final compounds behave as selective competitive inhibitors of beta-glucosidase and are promising candidates as pharmacological chaperones for Gaucher disease.
Stereocomplementary routes to hydroxylated nitrogen heterocycles: total syntheses of casuarine, australine, and 7-epi-australine.[Pubmed:23828462]
Chemistry. 2013 Aug 5;19(32):10595-604.
Addition of lithiated 1-benzyloxyallene to a D-arabinose-derived cyclic nitrone occurred with perfect diastereoselectivity furnishing a bicyclic 1,2-oxazine derivative, which is an excellent precursor for pyrrolizidine alkaloids hydroxylated at C-7 with optional configuration at this stereogenic center. Depending on the stage of the N-O bond cleavage and ring re-closure, 7-hydroxypyrrolizidines with 7R or 7S configuration were obtained, as a result of completely selective addition reactions occurring complementarily at the bottom or top face of the endocyclic C-C double bond in six- and five-membered B rings, respectively. Applicability of these stereodivergent routes to obtain polyhydroxy pyrrolizidine alkaloids is demonstrated by the efficient syntheses of casuarine and Australine as examples of the two classes of diversely configured 7-hydroxypyrrolizidine alkaloids. An alternative synthesis of Australine and two strategies for the preparation of 7-epi-Australine are also reported, which demonstrate that the stereoselectivity of hydride reduction of an exocyclic C-O double bond is independent of the ring size, occurring preferentially from the top face either in a six- or five-membered ring.
Australine, a pyrrolizidine alkaloid that inhibits amyloglucosidase and glycoprotein processing.[Pubmed:2497772]
Biochemistry. 1989 Mar 7;28(5):2027-34.
Australine [(1R,2R,3R,7S,7aR)-3-(hydroxymethyl)-1,2,7-trihydroxypyrrolizid ine] is a polyhydroxylated pyrrolizidine alkaloid that was isolated from the seeds of the Australian tree Castanospermum australe and characterized by NMR and X-ray diffraction analysis [Molyneux et al. (1988) J. Nat. Prod. (in press)]. Since swainsonine and catanospermine are polyhydroxylated indolizidine alkaloids that inhibit specific glycosidases, we tested Australine against a variety of exoglycosidases to determine whether it would inhibit any of these enzymes. This alkaloid proved to be a good inhibitor of the alpha-glucosidase amyloglucosidase (50% inhibition at 5.8 microM), but it did not inhibit beta-glucosidase, alpha- or beta-mannosidase, or alpha- or beta-galactosidase. The inhibition of amyloglucosidase was of a competitive nature. Australine also inhibited the glycoprotein processing enzyme glucosidase I, but had only slight activity toward glucosidase II. When incubated with cultured cells, this alkaloid inhibited glycoprotein processing at the glucosidase I step and caused the accumulation of glycoproteins with Glc3Man7-9(GlcNAc)2-oligosaccharides.
Synthesis and glycosidase inhibition of australine and its fluorinated derivatives.[Pubmed:25621897]
Org Lett. 2015 Feb 6;17(3):716-9.
Australine (1), 7-epi-Australine (2), and their C-7-fluorinated derivatives 4 and 5 have been synthesized efficiently from D-arabinose-derived cyclic nitrone 11. Fluorination at the C-7 position enhanced the inhibition against A. niger alpha-glucosidase, and this constitutes the first example of fluorination substitution for a hydroxyl increasing the inhibition of any glycosidases. The enantiomers synthesized from nitrone ent-11 showed no inhibition of the corresponding enzymes.
Total synthesis of uniflorine A, casuarine, australine, 3-epi-australine, and 3,7-di-epi-australine from a common precursor.[Pubmed:20028000]
J Org Chem. 2010 Feb 5;75(3):815-24.
A flexible method for the diastereoselective total synthesis of the pyrrolizidine alkaloids uniflorine A, casuarine, Australine, and 3-epi-Australine and the unnatural epimer 3,7-di-epi-Australine from a common chiral 2,5-dihydropyrrole precursor is described.